Phase 1b/2a study of trastuzumab emtansine (T-DM1), paclitaxel, and pertuzumab in HER2-positive metastatic breast cancer

Overview of attention for article published in Breast Cancer Research, March 2016

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 44,181 followers.

RT @NatRevClinOncol: Trial highlights potential for addition of paclitaxel to T-DM1 ± pertuzumab for metastatic #breastcancer: https://t.co…

Trial highlights potential for addition of paclitaxel to T-DM1 ± pertuzumab for metastatic #breastcancer: https://t.co/K5MoJM7UfG #BCSM

Phase 1b/2a study of trastuzumab emtansine (T-DM1), paclitaxel, and pertuzumab in HER2-positive… https://t.co/XEoytq3ZdY #breastcancer

Phase 1b/2a study of trastuzumab emtansine TDM1, paclitaxel and pertuzumab in HER2-positive metastatic breast cancer https://t.co/1NRkjx3YFD

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.